Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02243709 · ClinicalTrials.gov registry record · Phase 1
Mifepristone for the Prevention of Relapses of Alcohol Drinking
A Phase 1 study, sponsored by Brown University.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT02243709: Completed Phase 1 study, sponsored by Brown University.
NCT02243709 is a Phase 1 study that has completed, run by Brown University. The registered enrollment target is 32 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02243709, a Phase 1 study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
The goal of this study is to determine if, under stress, alcohol drinking is reduced using mifepristone
Primary Outcome
Safety and tolerability was assessed by the number of participants who experienced adverse events (AEs) while taking the medication, in the mifepristone group verses the placebo group during Visit 2 through and until Visit 5. AEs were assessed at each visit and special attention was paid to any AEs experienced after administration of the oral administration of mifepristone or placebo- Visit 2 to Visit 3 (7 days total) and Visit 4 through Visit 5 (7 days total), and when it was administered with
Interventions
- DRUG Mifepristone 600-mg/day or placebo for a week
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2014-09 |
| Est. Completion | 2021-12-21 |
| Phase | Phase 1 |
What the finished NCT02243709 record still lists
NCT02243709 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 1 intervention - of which Mifepristone 600-mg/day or placebo for a week is the first listed.
NCT02243709 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02243709 about?
NCT02243709 is a clinical study titled "Mifepristone for the Prevention of Relapses of Alcohol Drinking". The goal of this study is to determine if, under stress, alcohol drinking is reduced using mifepristone
What is the current status of trial NCT02243709?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2014-09. Estimated completion is 2021-12-21.
What interventions are being tested in trial NCT02243709?
The interventions under investigation include: Mifepristone 600-mg/day or placebo for a week (DRUG).
Who is sponsoring clinical trial NCT02243709?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02243709's enrollment target sits among peer trials
32 1296th of 2000 higher than 679 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia